MedPath

Management of Asthma Patients Guided by Exhaled Nitric Oxide (eNO)

Phase 4
Terminated
Conditions
Asthma
Registration Number
NCT00739219
Lead Sponsor
Apieron
Brief Summary

This study is designed to show that pharmacotherapy guided by eNO and clinical standard of care produces a superior outcome to trial-based therapy guided by clinical standard of care alone.

Detailed Description

Patients with persistent, moderate to severe asthma will be randomized to receive therapy guided by either eNO and clinical standard of care (eNO group) or clinical standard of care (control group). An eNO treatment algorithm will be established for each patient in the eNO group at Baseline (Visit 1). Enrollment is estimated to be six months with a follow up period of twelve months.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
260
Inclusion Criteria
  • Pre-existing diagnosis of asthma
  • Persistent, moderate or severe asthma as classified by NAEPP
  • Sub-optimally controlled asthma
  • Initiated ICS therapy for at least the past 30 days and a history of improvement of asthma control on steroids
Exclusion Criteria
  • Active cigarette smoking or β‰₯ 10 pack-years smoking history
  • Xolair taken in the past 6 months prior to enrollment
  • Oral prednisone taken in the last 4 weeks prior to enrollment
  • Cystic Fibrosis, COPD, ciliary dyskinesia, chest wall deformities or scoliosis
  • Subject is currently enrolled in another investigational drug study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Asthma control days12 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (12)

Southern California Research

πŸ‡ΊπŸ‡Έ

Mission Viejo, California, United States

Allergy & Asthma Associates of Santa Clara Valley Research Center

πŸ‡ΊπŸ‡Έ

San Jose, California, United States

Allergy Associates of Hartford

πŸ‡ΊπŸ‡Έ

Glastonbury, Connecticut, United States

Asthma and Allergy Center of Chicago, S.C.

πŸ‡ΊπŸ‡Έ

River Forest, Illinois, United States

The Asthma- Allergy Clinic& Research Center

πŸ‡ΊπŸ‡Έ

Shreveport, Louisiana, United States

Chesapeake Clinical Research

πŸ‡ΊπŸ‡Έ

Baltimore, Maryland, United States

The Clinical Research Center, LLC

πŸ‡ΊπŸ‡Έ

St. Louis, Missouri, United States

Center for Allergy and Asthma

πŸ‡ΊπŸ‡Έ

Highland Park, New Jersey, United States

Pulmonary & Allergy Associates P.A.

πŸ‡ΊπŸ‡Έ

Summit, New Jersey, United States

Allergy, Asthma & Dermatology Research Center, LLC

πŸ‡ΊπŸ‡Έ

Lake Oswego, Oregon, United States

Scroll for more (2 remaining)
Southern California Research
πŸ‡ΊπŸ‡ΈMission Viejo, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.